MA Cerquera-Jaramillo, MO Nava-Mesa… - Neural …, 2018 - Wiley Online Library
Alzheimer's disease (AD) is the leading cause of dementia worldwide. It compromises patients' daily activities owing to progressive cognitive deterioration, which has elevated …
Y Mao, Y He, L Liu, X Chen - Frontiers in neuroscience, 2020 - frontiersin.org
Medical research shows that eye movement disorders are related to many kinds of neurological diseases. Eye movement characteristics can be used as biomarkers of …
Affective computing (also referred to as artificial emotion intelligence or emotion AI) is the study and development of systems and devices that can recognize, interpret, process, and …
An opportune early diagnosis of Alzheimer's disease (AD) would help to overcome symptoms and improve the quality of life for AD patients. Research studies have identified …
MA Parra, S Butler, WJ McGeown… - Journal of global …, 2019 - ncbi.nlm.nih.gov
December 2019• Vol. 9 No. 2• 020310 2 www. jogh. org• doi: 10.7189/jogh. 09.020310 ing in the opposite direction, with LMIC tending to exhibit increasing cardiovascular risk …
K Walter, P Bex - Plos one, 2022 - journals.plos.org
Growing evidence links eye movements and cognitive functioning, however there is debate concerning what image content is fixated in natural scenes. Competing approaches have …
The leading trends in the framework of the Internet of Things are driving the research community to provide smart systems and solutions aimed at revolutionizing medical …
S Hartmann, TB Ledur Kist - Biomarkers in Medicine, 2018 - Taylor & Francis
The discovery of biomarkers that confer high confidence of presymptomatic Alzheimer's disease (AD) diagnosis would be a valuable tool to study the etiology of the disease, to find …
Eye movement assessments have the potential to help in diagnosis and tracking of neurological disorders. Cerebellar ataxias cause profound and characteristic abnormalities …